Peg Taylor

Peg Taylor is an accomplished clinical operations executive with extensive experience leading clinical trials across various biotechnology firms. Currently serving as Vice President of Clinical Operations at Oruka Therapeutics since June 2025, Peg Taylor provides strategic and tactical leadership to ensure high-quality outcomes in clinical trials. Previous roles include Vice President of Clinical Development Operations at Synthekine, Executive Director of Clinical Operations at CRISPR Therapeutics, and Vice President of Clinical Operations at Adicet Bio, Inc. Additional experiences span senior positions at Nektar Therapeutics, Genentech, Bayhill Therapeutics, IQVIA, Telik, Inc., and MedImmune. Peg Taylor holds a Bachelor of Science degree in Nutrition Science from the University of California, Davis.